12 Jun 2024
7m
Jim Cramer looks at Eli Lilly's outlook as the company's Alzheimer drug goes through FDA
CNBC Television
Open in Podwise to generate AI notes
Sign in to process this episode and unlock summaries, transcripts, highlights and translations.
Shownotes are not generated by Podwise.